Showing results (31-40 of 137) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Prostate brachytherapy and second primary cancer risk: a competitive risk analysisKarel A Hinnen, Michael Schaapveld, Marco van Vulpen, et al.
Urologic Oncology|July 12, 2014
Self-reported acne is not associated with prostate cancerRuben G Cremers, Katja K Aben, Sita H Vermeulen, et al.
BJU International|August 14, 2012
Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aidJulia J van Tol-Geerdink, Jan Willem Leer, Philip C Weijerman, et al.
The Journal of Urology|December 17, 2009
Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigenThomas Hambrock, Diederik M Somford, Caroline Hoeks, et al.
Cancers|February 25, 2022
The Feasibility of Implementing Mainstream Germline Genetic Testing in Routine Cancer Care-A Systematic ReviewKyra Bokkers, Michiel Vlaming, Ellen G Engelhardt, et al.
Health Informatics Journal|October 1, 2019
Implementation of a decision aid for localized prostate cancer in routine care: A successful implementation strategyJulia J van Tol-Geerdink, Inge M van Oort, Diederik M Somford, et al.
The Prostate|January 14, 2018
Epigenetic markers in circulating cell-free DNA as prognostic markers for survival of castration-resistant prostate cancer patientsRianne J Hendriks, Siebren Dijkstra, Frank P Smit, et al.
JCO Precision Oncology|January 20, 2022
A Systematic Review and Meta-Analysis on the Predictive Value of Cell-Free DNA-Based Androgen Receptor Copy Number Gain in Patients With Castration-Resistant Prostate CancerSofie H Tolmeijer, Emmy Boerrigter, Jack A Schalken, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|May 6, 2015
Does a decision aid for prostate cancer affect different aspects of decisional regret, assessed with new regret scales? A randomized, controlled trialJulia J van Tol-Geerdink, Jan Willem H Leer, Carl J Wijburg, et al.
International Journal of Molecular Sciences|June 14, 2013
Value of PCA3 to predict biopsy outcome and its potential role in selecting patients for multiparametric MRIGisele H J M Leyten, Elisabeth A Wierenga, J P Michiel Sedelaar, et al.
Pageof 14